Good start to 2022 for IBX!
Should see some of that hard work coming to fruition over the next two quarters.
For the time being, there is nothing to report till it is done, I guess; but, that shouldn't
be too much longer if (as anticipated) traction is being gained throughout the clinical
sites that are based in the three major Aust states.
